Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HBsAb ELISA Kit

HBsAb Reaktivität: Hepatitis B Virus (HBV) Colorimetric Sandwich ELISA Serum
Produktnummer ABIN997016
  • Target Alle HBsAb Produkte
    HBsAb (Anti-Hepatitis B Virus Surface Antibody (HBsAb))
    Reaktivität
    • 4
    • 4
    • 3
    • 1
    • 1
    • 1
    Hepatitis B Virus (HBV)
    Nachweismethode
    Colorimetric
    Methodentyp
    Sandwich ELISA
    Applikation
    ELISA
    Verwendungszweck
    HBsAb ELISA Test is an enzyme linked immunosorbent assay (ELISA) for in vitro qualitative detection of antibodies to hepatitis B virus surface antigen (anti-HBs) in human serum or plasma.
    Proben
    Serum
    Analytische Methode
    Qualitative
    Spezifität
    99.70%
    Sensitivität
    100%
  • Probenmenge
    50 μL
    Testdauer
    1 - 2 h
    Plattentyp
    Pre-coated
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Lagerung
    4 °C
    Haltbarkeit
    12-18 months
  • Target Alle HBsAb Produkte
    HBsAb (Anti-Hepatitis B Virus Surface Antibody (HBsAb))
    Andere Bezeichnung
    HbsAb (HBsAb Produkte)
    Substanzklasse
    Antibody, Antibody
    Hintergrund
    Hepatitis B virus (HBV) is an enveloped, double-stranded DNA virus belonging to the Hepadnaviridae family and is recognized as the major cause of blood transmitted hepatitis together with hepatitis C virus (HCV). Infection with HBV induces a spectrum of clinical manifestations ranging from mild, inapparent disease to fulminant hepatitis, severe chronic liver disease, which in some cases can lead to cirrhosis and carcinoma of the liver. Classification of a hepatitis B infection requires the identification of several serological markers expressed during three phases (incubation, acute and convalescent) of the infection. Now several diagnostic tests are used for screening, clinical diagnosis and management of the disease. Hepatitis B surface antigen (HBsAg), which appears shortly after infection is an important protein of the envelope structure of the virus.
    HBsAg is a key serological marker for detection and diagnosis of HBV and is detectable in blood during the acute phase of the disease. Clearance after treatment shows recovery while presence for more than half year after infection indicates possible progression to long chronic carrier stage. During the acute phase of the infection, strong immunological response develops and increasing titers of HBsAg neutralizing antibodies (anti-HBs) are marker for recovery. The serological detection of anti-HBs has become important method for the follow up of patients infected by HBV, prospective prevalence studies, and the monitoring of recipients upon vaccination with synthetic and natural HBsAg based vaccines.
Sie sind hier:
Kundenservice